2023 - Research.com Medicine in Sweden Leader Award
2022 - Research.com Best Female Scientist Award
2016 - Member of Academia Europaea
Her primary scientific interests are in Alzheimer's disease, Internal medicine, Endocrinology, Neuroscience and Pathology. Her biological study spans a wide range of topics, including Degenerative disease, Dementia and Amyloid. Her studies deal with areas such as Positron emission tomography, Predictive value of tests and Frontotemporal dementia as well as Amyloid.
Agneta Nordberg works mostly in the field of Internal medicine, limiting it down to topics relating to Human brain and, in certain cases, Caudate nucleus, as a part of the same area of interest. Her study in Endocrinology is interdisciplinary in nature, drawing from both Receptor, Nicotinic agonist and Acetylcholine receptor. Her Disease research is multidisciplinary, incorporating perspectives in Pathological, Psychiatry, Neurology, Intensive care medicine and Biomarker.
Agneta Nordberg mainly investigates Internal medicine, Endocrinology, Alzheimer's disease, Disease and Nicotinic agonist. Her work carried out in the field of Internal medicine brings together such families of science as Acetylcholinesterase and Oncology. Pathology covers Agneta Nordberg research in Alzheimer's disease.
Her studies deal with areas such as Positron emission tomography and In vivo as well as Pathology. Her study in the field of Dementia also crosses realms of Context. Her Nicotinic agonist study combines topics in areas such as Nicotine, Pharmacology and Acetylcholine receptor.
The scientist’s investigation covers issues in Disease, Positron emission tomography, Internal medicine, Dementia and Biomarker. She has researched Disease in several fields, including Carbohydrate metabolism, Neuroimaging and Astrocyte. Her biological study spans a wide range of topics, including Cognition and Oncology.
Her Dementia research is multidisciplinary, relying on both Differential diagnosis, Cognitive impairment and Intensive care medicine. Her Biomarker study incorporates themes from Alzheimer's disease, Florbetaben, Neurodegeneration and Phospho tau. Her research on Alzheimer's disease often connects related topics like Hippocampus.
Her main research concerns Dementia, Disease, Neurodegeneration, Positron emission tomography and Neurology. Her Dementia research is under the purview of Internal medicine. In the subject of general Internal medicine, her work in Amyloid pet is often linked to Population study, thereby combining diverse domains of study.
Her Disease research includes elements of Biomarker, Incidence and Astrocyte. The concepts of her Positron emission tomography study are interwoven with issues in Fibril, Biophysics, Molecular model, Binding site and Amyloid. Her Neurology study integrates concerns from other disciplines, such as Progressive supranuclear palsy and Cerebrospinal fluid, Pathophysiology, Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E. Klunk;Henry Engler;Agneta Nordberg;Yanming Wang.
Annals of Neurology (2004)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)
Neuronal nicotinic receptors in the human brain
David Paterson;Agneta Nordberg.
Progress in Neurobiology (2000)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg;Henry Engler;Ove Almkvist;Ove Almkvist;Ove Almkvist;Gunnar Blomquist.
Neurobiology of Aging (2008)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Henry Engler;Anton Forsberg;Ove Almkvist;Gunnar Blomquist.
PET imaging of amyloid in Alzheimer's disease.
Lancet Neurology (2004)
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Maria Eriksdotter Jönhagen;Agneta Nordberg;Kaarina Amberla;Lars Bäckman.
Dementia and Geriatric Cognitive Disorders (1998)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: